PEACHI header v5 FP7-gen-RGB EU flag

Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections

A collaborative project financed by the EC Framework Programme 7

Work Package 3 - Safety & immunogenicity of ChAd3 Ii-NSmut and MVA Ii-NSmut in healthy and HIV-positive adults

Objective: To assess the safety and immunogenicity of second generation viral vectored technology using ChAd3 and MVA, employing NSmut linked to the human MHC class II invariant chain, in both healthy subjects and HIV-positive patients (PEACHI-03).


Work Package Lead: Kantonsspital, St Gallen


Summary of Tasks:

Quick links:

WP3 13Dec13